BVS vs CSGP · rev $573.3M vs P/E 484, rev $2.74B
Bioventus Inc (BVS) versus CoStar Group Inc (CSGP) — a side-by-side from cached financials, not a winner call.
Bioventus Inc (BVS) is a medical devices company listed on US.
CoStar Group Inc (CSGP) is a real estate services company listed on US.
Latest reported BVS revenue for 2024-12-31 was $573.3M. Net income was -$43.8M. Revenue was up 11.9% from 2023-12-31 to 2024-12-31. BVS currently screens at market cap $495.1M.
Latest reported CSGP revenue for 2024-12-31 was $2.74B. Net income was $138.7M. Revenue was up 11.5% from 2023-12-31 to 2024-12-31. CSGP currently screens at market cap $13.84B and trailing P/E 484.1.
BVS currently screens at market cap $495.1M. CSGP currently screens at market cap $13.84B and trailing P/E 484.1.
Not investment advice. Open the BVS and CSGP stock pages for the full models.
Not investment advice.